ReviewHuman vaccines & immunotherapeutics2018
Talimogene laherparepvec: First in class oncolytic virotherapy.
Robert M Conry et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
186 papers cite itlatest 60 shown
this paperpooled ittrialcites it